Baldwin Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
15,669
-1,485
-9% -$174K 0.13% 84
2026
Q1
$2.06M Sell
17,154
-25,395
-60% -$2.93M 0.15% 79
2025
Q4
$4.48M Sell
42,549
-5,624
-12% -$528K 0.29% 56
2025
Q3
$4.04M Sell
48,173
-149,889
-76% -$12.3M 0.26% 62
2025
Q2
$15.7M Sell
198,062
-2,488
-1% -$198K 1.06% 27
2025
Q1
$18M Buy
200,550
+3,794
+2% +$354K 1.26% 23
2024
Q4
$19.6M Buy
196,756
+7,636
+4% +$787K 1.35% 21
2024
Q3
$21.5M Buy
189,120
+6,189
+3% +$735K 1.46% 18
2024
Q2
$22.6M Sell
182,931
-7,719
-4% -$994K 1.76% 15
2024
Q1
$25.2M Sell
190,650
-1,921
-1% -$237K 1.89% 14
2023
Q4
$21M Buy
192,571
+6,307
+3% +$655K 1.65% 17
2023
Q3
$19.2M Sell
186,264
-3,863
-2% -$416K 1.65% 16
2023
Q2
$21.9M Sell
190,127
-48
-0% -$5.45K 1.8% 12
2023
Q1
$20.2M Sell
190,175
-2,655
-1% -$287K 1.76% 11
2022
Q4
$21.4M Buy
192,830
+16,726
+9% +$1.71M 1.94% 10
2022
Q3
$15.2M Sell
176,104
-2,795
-2% -$250K 2.1% 15
2022
Q2
$16.3M Sell
178,899
-8,954
-5% -$794K 2.11% 12
2022
Q1
$15.4M Buy
187,853
+2,814
+2% +$222K 1.63% 18
2021
Q4
$14.2M Buy
185,039
+999
+0.5% +$79.6K 1.42% 23
2021
Q3
$13.8M Buy
184,040
+708
+0.4% +$53.8K 1.53% 21
2021
Q2
$14.3M Sell
183,332
-8,850
-5% -$658K 1.56% 22
2021
Q1
$14.1M Buy
192,182
+4,810
+3% +$355K 1.68% 20
2020
Q4
$14.6M Sell
187,372
-1,254
-0.7% -$95.9K 1.84% 16
2020
Q3
$14.9M Sell
188,626
-3,223
-2% -$252K 2.04% 14
2020
Q2
$14.2M Sell
191,849
-1,131
-0.6% -$85.1K 2.08% 14
2020
Q1
$14.2M Buy
192,980
+3,429
+2% +$269K 2.48% 11
2019
Q4
$16.4M Sell
189,551
-181
-0.1% -$14.9K 2.3% 8
2019
Q3
$15.2M Sell
189,732
-139
-0.1% -$11.1K 2.29% 9
2019
Q2
$15.2M Sell
189,871
-3,092
-2% -$237K 2.24% 12
2019
Q1
$15.3M Sell
192,963
-16,502
-8% -$1.23M 2.28% 11
2018
Q4
$15.3M Sell
209,465
-1,447
-0.7% -$102K 2.56% 7
2018
Q3
$14.3M Sell
210,912
-30,958
-13% -$1.97M 2% 12
2018
Q2
$14M Sell
241,870
-956
-0.4% -$53.9K 2.18% 12
2018
Q1
$12.6M Buy
242,826
+12,280
+5% +$663K 2.04% 11
2017
Q4
$12.4M Sell
230,546
-6,213
-3% -$344K 1.93% 15
2017
Q3
$14.5M Buy
236,759
+121
+0.1% +$7.34K 2.33% 11
2017
Q2
$14.5M Sell
236,638
-5,267
-2% -$321K 2.33% 9
2017
Q1
$14.7M Buy
241,905
+28,380
+13% +$1.72M 2.42% 9
2016
Q4
$12M Buy
213,525
+1,916
+0.9% +$112K 2.17% 14
2016
Q3
$12.6M Buy
211,609
+1,407
+0.7% +$82.3K 2.29% 12
2016
Q2
$11.6M Buy
210,202
+11,031
+6% +$587K 2.38% 13
2016
Q1
$10.1M Buy
199,171
+30,339
+18% +$1.49M 1.8% 16
2015
Q4
$8.51M Sell
168,832
-11,519
-6% -$581K 1.39% 23
2015
Q3
$8.5M Buy
180,351
+602
+0.3% +$32K 1.43% 23
2015
Q2
$9.76M Buy
179,749
+1,813
+1% +$102K 1.45% 22
2015
Q1
$9.76M Buy
177,936
+32,641
+22% +$1.85M 1.44% 24
2014
Q4
$7.87M Sell
145,295
-1,929
-1% -$107K 1.14% 31
2014
Q3
$8.33M Buy
147,224
+18,173
+14% +$1.02M 1.18% 30
2014
Q2
$7.12M Buy
129,051
+2,479
+2% +$135K 1.06% 33
2014
Q1
$6.86M Buy
126,572
+11,512
+10% +$596K 1.1% 31
2013
Q4
$5.5M Buy
115,060
+13,844
+14% +$633K 0.88% 38
2013
Q3
$4.6M Buy
101,216
+6,147
+6% +$281K 0.84% 40
2013
Q2
$4.21M Buy
+95,069
New +$4.25M 0.83% 40

Other funds holding MRK

Baldwin Wealth Partners's MRK Position: Q2 2026 in Review

Baldwin Wealth Partners reduced its Merck (MRK) stake by 8.7% in Q2 2026, selling an estimated $174K and leaving 15,669 shares worth $2.01M. The position accounts for 0.13% of the portfolio, ranked #84.

Baldwin Wealth Partners first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.2M in Q1 2024. 1,789 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Baldwin Wealth Partners held 15,669 shares of Merck worth $2.01M as of Q2 2026.
  • Baldwin Wealth Partners sold 1,485 Merck shares in Q2 2026, an estimated $174K.
  • Merck made up 0.13% of Baldwin Wealth Partners's portfolio in Q2 2026, its #84 holding.
  • Baldwin Wealth Partners first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Baldwin Wealth Partners's Merck position peaked at $25.2M in Q1 2024.
  • 1,789 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.